NTN BUZZTIME INC | Human Resources | Business Contracts

Separation Agreement and General Release, dated May 2, 2023, by and between Eterna Therapeutics Inc. and Andrew Jackson (Filed With SEC on May 5, 2023)

Separation Agreement and General Release, dated August 24, 2022, by and between Brooklyn ImmunoTherapeutics, Inc. and Kevin DAmour (Filed With SEC on September 1, 2022)

Amended and Restated Executive Employment Agreement, dated as of May 10, 2022, by and between Brooklyn ImmunoTherapeutics, Inc. and Andrew Jackson (Filed With SEC on May 31, 2022)

Separation Agreement and General Release, dated May 25, 2022, by and between Brooklyn ImmunoTherapeutics, Inc. and Howard J. Federoff (Filed With SEC on May 31, 2022)

Executive Employment Agreement effective as of September 20, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Roger Sidhu (Filed With SEC on September 23, 2021)

Executive Employment Agreement, dated as of July 6, 2021 and effective as of July 15, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Jay Sial (Filed With SEC on July 19, 2021)

Executive Employment Agreement, dated as of June 16, 2021 and effective as of June 21, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Sandra Gurrola (Filed With SEC on June 21, 2021)

Executive Employment Agreement, dated as of June 5, 2021 and effective as of June 28, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Kevin A. DAmour (Filed With SEC on June 10, 2021)

Brooklyn ImmunoTherapeutics, Inc. 2021 Inducement Stock Incentive Plan (Filed With SEC on May 26, 2021)

Executive Employment Agreement, dated as of April 1, 2021 and effective as of April 16, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Howard J. Federoff (Filed With SEC on April 7, 2021)

Brooklyn ImmunoTherapeutics, Inc. 2020 Stock Incentive Plan (Filed With SEC on March 31, 2021)

Assignment and Assumption of Employment Agreement dated March 30, 2021 among Brooklyn ImmunoTherapeutics LLC, Brooklyn ImmunoTherapeutics, Inc. and Ronald Guido (Filed With SEC on March 31, 2021)

Assignment and Assumption of Employment Agreement dated March 30, 2021 among Brooklyn ImmunoTherapeutics LLC, Brooklyn ImmunoTherapeutics, Inc. and Lynn Sadowski Mason (Filed With SEC on March 31, 2021)

Amendment #4 to Employment Agreement made and entered into as of September 18, 2020 between NTN Buzztime, Inc. and Allen Wolff (Filed With SEC on September 18, 2020)

Second Amendment to Employment Agreement dated May 27, 2020 by and between NTN Buzztime, Inc. and Sandra Gurrola (Filed With SEC on June 2, 2020)

Retention Bonus and General Release of All Claims Agreement dated May 27, 2020 by and between NTN Buzztime, Inc. and Sandra Gurrola (Filed With SEC on June 2, 2020)

NTN Buzztime, Inc. Executive Incentive Plan for Eligible Employees of NTN Buzztime, Inc. Fiscal Year 2020 (Filed With SEC on June 2, 2020)

Third Amendment to Employment Agreement dated March 27, 2020 by and between NTN Buzztime, Inc. and Allen Wolff (Filed With SEC on March 30, 2020)

Second Amendment to Employment Agreement dated January 14, 2020 by and between NTN Buzztime, Inc. and Allen Wolff (Filed With SEC on January 15, 2020)

First Amendment to Employment Agreement dated January 14, 2020 by and between NTN Buzztime, Inc. and Sandra Gurrola (Filed With SEC on January 15, 2020)

First Amendment to Employment Agreement dated September 17, 2019 by and between NTN Buzztime, Inc. and Allen Wolff (Filed With SEC on September 17, 2019)

2019 Interim CEO Performance Incentive Plan (Filed With SEC on September 17, 2019)

Employment Agreement dated September 17, 2019 by and between NTN Buzztime, Inc. and Sandra Gurrola (Filed With SEC on September 17, 2019)

Limited Term Employment and Separation Agreement and General Release of All Claims dated Separation 17, 2019 by and between NTN Buzztime, Inc. and Ram Krishnan (Filed With SEC on September 17, 2019)

The NTN Buzztime, Inc. Executive Incentive Plan for Eligible Employees of NTN Buzztime, Inc. Fiscal Year 2019 dated March 19, 2019 (Filed With SEC on March 20, 2019)

NTN BUZZTIME INC (177) | Human Resources (25)